UBS Group’s Applied DNA Sciences Inc Warrant APDNW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-18,435
| Closed | – | – | 8732 |
|
|
2019
Q3 | $0 | Buy |
18,435
+14,411
| +358% | +$95 | ﹤0.01% | 8497 |
|
|
2019
Q2 | $0 | Hold |
4,024
| – | – | ﹤0.01% | 8408 |
|
|
2019
Q1 | $0 | Sell |
4,024
-301
| -7% | -$5 | ﹤0.01% | 8480 |
|
|
2018
Q4 | $0 | Buy |
4,325
+800
| +23% | +$74 | ﹤0.01% | 8519 |
|
|
2018
Q3 | $1K | Buy |
3,525
+425
| +14% | +$97 | ﹤0.01% | 7904 |
|
|
2018
Q2 | $1K | Buy |
+3,100
| New | +$855 | ﹤0.01% | 7885 |
|
|
2017
Q4 | – | Sell |
-2,205
| Closed | -$2K | – | 8265 |
|
|
2017
Q3 | $2K | Sell |
2,205
-5,300
| -71% | -$2.53K | ﹤0.01% | 7521 |
|
|
2017
Q2 | $3K | Buy |
7,505
+5,169
| +221% | +$1.8K | ﹤0.01% | 7331 |
|
|
2017
Q1 | $1K | Sell |
2,336
-564
| -19% | -$256 | ﹤0.01% | 7512 |
|
|
2016
Q4 | $1K | Buy |
2,900
+2,582
| +812% | +$2.05K | ﹤0.01% | 7680 |
|
|
2016
Q3 | $0 | Buy |
+318
| New | +$341 | ﹤0.01% | 8106 |
|
|
2015
Q4 | – | Sell |
-1,999
| Closed | -$6K | – | 8698 |
|
|
2015
Q3 | $6K | Sell |
1,999
-801
| -29% | -$1.33K | ﹤0.01% | 7634 |
|
|
2015
Q2 | $4K | Buy |
+2,800
| New | +$3.19K | ﹤0.01% | 8011 |
|
|
2015
Q1 | – | Sell |
-1,314
| Closed | -$2K | – | 9679 |
|
|
2014
Q4 | $2K | Buy |
+1,314
| New | +$1.3K | ﹤0.01% | 9455 |
|
UBS Group's APDNW Position: Q4 2019 in Review
UBS Group sold out of Applied DNA Sciences Inc Warrant (APDNW) in Q4 2019, closing a stake of 18,435 shares.
UBS Group first reported a position in APDNW in Q4 2014 and held it in 14 quarters. The position peaked at $6K in Q3 2015. 0 funds tracked by Wall St. Rank hold APDNW as of Q4 2019.
- UBS Group reported no remaining Applied DNA Sciences Inc Warrant position as of Q4 2019 after selling out during the quarter.
- UBS Group sold 18,435 Applied DNA Sciences Inc Warrant shares in Q4 2019.
- UBS Group first reported a position in Applied DNA Sciences Inc Warrant in Q4 2014 and held it in 14 quarters.
- UBS Group's Applied DNA Sciences Inc Warrant position peaked at $6K in Q3 2015.
- 0 funds tracked by Wall St. Rank held Applied DNA Sciences Inc Warrant as of Q4 2019.
Based on UBS Group's 13F filing for Q4 2019, filed 14 Feb 2020.